Participants | |||||||
---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | |
Years with ESRD | 23 | 14 | 5 | 14 | 12 | 11 | 12 |
Years on NHD | 6 | 1 | 1 | 11 | 11 | 8 | 9 |
Nights per week of NHD | 4 | 5 | 3 | 5 | 6 | 4 | 5 |
Hours per night of NHD | 8 | 7.5 | 9 | 8 | 7.5 | 8 | 8 |
History of cancer | No | Yes† | No | Yes† | No | No | Yes† |
History of ischaemic heart disease | No | No | No | No | No | No | No |
BMI (kg/m2) | 26.2 | 31.5 | 29.7 | 28 | 26.2 | 24.4 | 20.1 |
Albumin (g/L) | 44 | 36 | 43 | 40 | 33 | 38 | 38 |
Calcium (mmol/L) | 2.66 | 2.28 | 2.71 | 2.62 | 2.31 | 2.25 | 2.55 |
Phosphate (mmol/L) | 2.06 | 1.10 | 1.57 | 2.49 | 1.36 | 1.51 | 0.93 |
Haemoglobin (g/L) | 103 | 98 | 133 | 121 | 119 | 138 | 108 |
Antihypertensive drug use | No | No | No | Yes | No | Yes | No |
*Respondent characteristics including age, gender, race, underlying disease, previous transplant history and current employment status have not been included in this table to comply with norms in the publication of qualitative research designed to maintain confidentiality.16
†Respondent was cancer free at the time of decision regarding transplantation and was deemed transplant-eligible.
BMI, body mass index; ESRD, end-stage renal disease; NHD, nocturnal haemodialysis.